Oncogene Contents: Volume 41 Number 18

In this Issue: Review Article Article

Oncogene Contents: Volume 41 Issue 18

Review Article

MUTYH-associated tumor syndrome: The other face of MAP Luigi Magrin, Daniele Fanale, Chiara Brando, Lidia Rita Corsini, Ugo Randazzo et al. Review Article | 14 April 2022 Oncogene 41 | doi:10.1038/s41388-022-02304-y

Article

ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma Marina Georgiou, Panagiota Ntavelou, William Stokes, Rajat Roy, Geoffrey J. Maher et al. Article | 18 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02251-8

USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer Zhen Liu, Junhe Li, Yun Ding, Mei Ma, Jun Chen et al. Article | 22 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02267-0

Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation Margaux Sala, Nathalie Allain, Mélanie Moreau, Arnaud Jabouille, Elodie Henriet et al. Article | 23 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02266-1

Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer Takuya Shirakihara, Hideki Yamaguchi, Tadashi Kondo, Masakazu Yashiro & Ryuichi Sakai Article | 25 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02270-5

Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-β signaling Yiming Tu, Lei Xu, Jia Xu, Zhongyuan Bao, Wei Tian et al. Article | 25 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02275-0

GIPC2 interacts with Fzd7 to promote prostate cancer metastasis by activating WNT signaling Liang Wang, Jiayi Wang, Xiaolin Yin, Xin Guan, Ying Li et al. Article | 28 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02255-4

Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells Yao-Shun Yang, Xi-Zheng Jia, Qian-Yun Lu, Sun-Li Cai, Xue-Ting Huang et al. Article | 29 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02278-x

Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1 Daniel J. García-Domínguez, Nabil Hajji, Roser López-Alemany, Sara Sánchez-Molina, Elisabet Figuerola-Bou et al. Article | 30 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02279-w

H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth Chunwan Lu, Dafeng Yang, John D. Klement, Yolonda L. Colson, Nicholas H. Oberlies et al. Article | 30 March 2022 Oncogene 41 | doi:10.1038/s41388-022-02283-0

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Oncogene.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.